Cancer Management

Cancer Therapy Advisor’s cancer treatment resources now include the most recent guideline-based information to inform oncologists and oncology professionals about therapy selection for optimal patient outcomes. These articles provide accurate and up-to-date information about FDA-approved therapies commonly recommended in cancer treatment guidelines for different types of cancer, recent updates to US guidelines for cancer treatment, and adverse events and drug-drug interactions associated with certain therapies.

Don’t see the specific treatment guidance you need?

As we roll out resources for other cancer types, sign up to be notified via email when new cancer treatment guidelines are added. 

ACCESS THE ARTICLE

ACCESS THE ARTICLE

ACCESS THE ARTICLE

Pancreatic Cancer: Pharmacologic Management

Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent pancreatic malignancy. This condition represents approximately 3% of all cancers in the United States and approximately 7% of all cancer deaths.
ACCESS THE ARTICLE

Chest radiograph of a woman with breast cancer demonstrating multiple nodules of variable sizes throughout the lungs, suggestive of pulmonary metastasis.

Metastatic Breast Cancer: Pharmacologic Management

Breast cancer is the most common type of cancer, with an estimated 300,590 new cases in the United States in 2023. The National Cancer Institute also estimates that breast cancer will account for 43,170 to 43,530 new deaths in 2023.
ACCESS THE ARTICLE

ACCESS THE ARTICLE

ACCESS THE ARTICLE

ACCESS THE ARTICLE

ACCESS THE ARTICLE

breast cancer cells

Breast Cancer: Pharmacologic Management

The National Cancer Institute estimates that there will be 297,790 new cases of invasive breast cancer and 55,720 new cases of ductal carcinoma in situ (DCIS) diagnosed in 2023.
ACCESS THE ARTICLE

ACCESS THE ARTICLE

Bladder Cancer Guidelines

The best bladder cancer treatment option may include more than one type or combination of different treatments (chemotherapy, radiation, and surgery).
ACCESS THE ARTICLE

ACCESS THE ARTICLE

Lymph node with metastatic colonic adenocarcinoma

Colorectal Cancer: Pharmacologic Management

Colorectal cancer is the third most common cancer and the second leading cause of cancer death in the United States.1 Colorectal cancer is an umbrella term that refers to cancer of both the colon and the rectum.
ACCESS THE ARTICLE

ACCESS THE ARTICLE

ACCESS THE ARTICLE

G_bladder_cancer_micrograph

Bladder Cancer: Pharmacologic Management

Bladder cancer is the sixth most prevalent cancer in the United States. As of 2023, 82,290 new diagnoses of bladder cancer (62,420 in men and 19,870 in women) were documented, as well as 16,710 deaths.
ACCESS THE ARTICLE

ACCESS THE ARTICLE

Lymph node with metastatic colonic adenocarcinoma

Colon Cancer Guidelines

Colon cancer is the third most common cancer diagnosed in the United States. The overall lifetime risk of developing colorectal cancer is approximately 1 in 23 for men and 1 in 25 in women. Learn more about the staging, management, and prognosis of colon cancer.
ACCESS THE ARTICLE

The new risk score, developed by Emory researchers, could be a useful tool for determining overall and progression-free survival after immunotherapy.

Renal Cell Carcinoma Guidelines

Renal Cell Carcinoma is the 10th most common cancer. Most renal cancers arise from the epithelial tubules of the nephron. This reference covers risk factors, testing, prognosis, and treatments.
ACCESS THE ARTICLE

Urology consultation

Prostate Cancer Guidelines

Prostate cancer is the second most common type of cancer, and cancer death, in men in the United States with an estimated annual incidence of 268,490 cases and an estimated 34,500 deaths each year.
ACCESS THE ARTICLE

Pheochromocytoma (PH or PCC). Adrenal Gland Tumor

Pheochromocytoma Diagnosis & Treatment

Pheochromocytoma is a rare neuroendocrine disorder in which a tumor grows within the adrenal medulla. This tumor causes the continuous overproduction of epinephrine and norepinephrine, which, if left without treatment, can lead to severe or life-threatening damage to other body systems.
ACCESS THE ARTICLE

Pituitary Adenoma and Pregnancy

Pituitary adenomas are typically prolactinomas, which are the most frequent cause of elevated prolactin levels. Pituitary adenomas comprise over 85% of pituitary tumors, and 25% to 30% of these are hormonally inactive. The incidence of prolactinomas is four times greater in women than in men.
ACCESS THE ARTICLE